Clinical Trials Logo

Chronic Lymphocyte Leukemia clinical trials

View clinical trials related to Chronic Lymphocyte Leukemia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02232386 Active, not recruiting - Adult Patients Clinical Trials

Phase 2 Study to Assess Activity & Safety of Front-line Ibrutinib + Rituximab in Unfit Chronic Lymphocytic Leukemia

LLC1114
Start date: March 2, 2015
Phase: Phase 2
Study type: Interventional

The present study aims at evaluating whether treatment with two different drugs, Ibrutinib and Rituximab is both efficient and safe for newly diagnosed patients with chronic lymphocytic leukemia.